Evidence map›Paper›PMID 29710329›Full record

ArticleJAMA neurology2018

Chronic Meningitis Investigated via Metagenomic Next-Generation Sequencing.

Michael R Wilson, Brian D O'Donovan, Jeffrey M Gelfand, Hannah A Sample, Felicia C Chow, John P Betjemann, Maulik P Shah, Megan B Richie, Mark P Gorman, Rula A Hajj-Ali and 22 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in JAMA neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 169 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
169citing papers in PubMed, 2 pooled it
16.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

169 citing papers in PubMed, 2 syntheses or guidelines pooled it, 310 citations in OpenAlex.

  1. Global characteristics and trends in research onFrontiers in microbiology · 2023
    Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Chronic meningitis: diagnostic and therapeutic challenges.Current opinion in infectious diseases · 2025
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. HPD-Kit: a comprehensive toolkit for pathogen detection and analysis.Frontiers in cellular and infection microbiology · 2025
    Article
  20. Article

109 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

32 authors at 10 institutions in 2 countries.

Michael R WilsonUCSF (University of California, San Francisco) Weill Institute for Neurosciences, San Francisco, California.
Brian D O'DonovanDepartment of Biochemistry and Biophysics, UCSF, San Francisco.
Jeffrey M GelfandUCSF (University of California, San Francisco) Weill Institute for Neurosciences, San Francisco, California.
Hannah A SampleDepartment of Biochemistry and Biophysics, UCSF, San Francisco.
Felicia C ChowUCSF (University of California, San Francisco) Weill Institute for Neurosciences, San Francisco, California.
John P BetjemannUCSF (University of California, San Francisco) Weill Institute for Neurosciences, San Francisco, California.
Maulik P ShahUCSF (University of California, San Francisco) Weill Institute for Neurosciences, San Francisco, California.
Megan B RichieUCSF (University of California, San Francisco) Weill Institute for Neurosciences, San Francisco, California.
Mark P GormanDepartment of Neurology, Boston Children's Hospital, Boston, Massachusetts.
Rula A Hajj-AliDepartment of Rheumatology/Immunology, Cleveland Clinic, Cleveland, Ohio.
Leonard H CalabreseDepartment of Rheumatology/Immunology, Cleveland Clinic, Cleveland, Ohio.
Kelsey C ZornDepartment of Biochemistry and Biophysics, UCSF, San Francisco.
Eric D ChowDepartment of Biochemistry and Biophysics, UCSF, San Francisco.
John E GreenleeNeurology Service, George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, Utah.
Jonathan H BlumPermanente Medical Group, Inc, Oakland, California.
Gary GreenPermanente Medical Group, Inc, Oakland, California.
Lillian M KhanDepartment of Biochemistry and Biophysics, UCSF, San Francisco.
Debarko BanerjiUCSF (University of California, San Francisco) Weill Institute for Neurosciences, San Francisco, California.
Charles LangelierDivision of Infectious Diseases, Department of Medicine, UCSF, San Francisco.
Chloe Bryson-CahnDivision of Allergy and Infectious Diseases, Department of Medicine, School of Medicine, University of Washington, Seattle.
Whitney HarringtonDepartment of Pediatrics, University of Washington, Seattle.
Jairam R LingappaDivision of Allergy and Infectious Diseases, Department of Medicine, School of Medicine, University of Washington, Seattle.
Niraj M ShanbhagUCSF (University of California, San Francisco) Weill Institute for Neurosciences, San Francisco, California.
Ari J GreenUCSF (University of California, San Francisco) Weill Institute for Neurosciences, San Francisco, California.
Bruce J BrewDepartment of Neurology, St Vincent's Hospital, Darlinghurst, New South Wales, Australia.
Ariane SoldatosNational Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Services Bethesda, Maryland.
Luke StrnadDivision of Infectious Diseases, Department of Medicine, Oregon Health and Science University, Portland.
Sarah B DoernbergDivision of Infectious Diseases, Department of Medicine, UCSF, San Francisco.
Cheryl A JayUCSF (University of California, San Francisco) Weill Institute for Neurosciences, San Francisco, California.
Vanja DouglasUCSF (University of California, San Francisco) Weill Institute for Neurosciences, San Francisco, California.
S Andrew JosephsonUCSF (University of California, San Francisco) Weill Institute for Neurosciences, San Francisco, California.
Joseph L DeRisiDepartment of Biochemistry and Biophysics, UCSF, San Francisco.
University of California, San Francisco · USUniversity of Washington · USCleveland Clinic · USColorado Permanente Medical Group · USBoston Children's Hospital · USChan Zuckerberg Initiative (United States) · USGeorge E. Wahlen Department of VA Medical Center · USNational Institutes of Health · USOregon Health & Science University · USSt Vincent's Hospital Sydney · AU

Funding

HOST DEFENSE TRAINING IN ALLERGY AND INFECTIOUS DISEASEST32AI007044 · NIAID · UNIVERSITY OF WASHINGTON · PI DAVID Neal FREDRICKS · 1985 to 2026
$14.6M
Clinical and Transtional Science InstituteKL2TR000143 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GRANDIS, JENNIFER RUBIN · 2012 to 2015
$11.9M
BIOLOGY OF INFECTIOUS DISEASES TRAINING PROGRAMT32AI007641 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MATTHEW G DORSEY · 2000 to 2026
$6.9M
BMI Bioinformatics Training GrantsT32GM067547 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HERNANDEZ, RYAN D. · 2003 to 2022
$6.6M
Integrative Program in Complex Biological System (ipCBS)T32EB009383 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MARSHALL, WALLACE, WEINER, ORION D · 2009 to 2022
$3.2M
Next-Generation Diagnostics for Acute EncephalitisK08NS096117 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WILSON, MICHAEL R · 2017 to 2021
$999k
Profiling the Lung Transcriptome for Precision Diagnosis of Respiratory Infections using Host/Pathogen Metagenomic SequencingK23HL138461 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LANGELIER, CHARLES · 2018 to 2021
$718k
NCATS NIH HHS KL2 TR000143NHLBI NIH HHS K23 HL138461NIAID NIH HHS T32 AI007044NIAID NIH HHS T32 AI007641NIBIB NIH HHS T32 EB009383NIGMS NIH HHS T32 GM067547NINDS NIH HHS K08 NS096117
6 · The paper itself

Abstract

Importance: Identifying infectious causes of subacute or chronic meningitis can be challenging. Enhanced, unbiased diagnostic approaches are needed. Objective: To present a case series of patients with diagnostically challenging subacute or chronic meningitis using metagenomic next-generation sequencing (mNGS) of cerebrospinal fluid (CSF) supported by a statistical framework generated from mNGS of control samples from the environment and from patients who were noninfectious. Design, Setting, and Participants: In this case series, mNGS data obtained from the CSF of 94 patients with noninfectious neuroinflammatory disorders and from 24 water and reagent control samples were used to develop and implement a weighted scoring metric based on z scores at the species and genus levels for both nucleotide and protein alignments to prioritize and rank the mNGS results. Total RNA was extracted for mNGS from the CSF of 7 participants with subacute or chronic meningitis who were recruited between September 2013 and March 2017 as part of a multicenter study of mNGS pathogen discovery among patients with suspected neuroinflammatory conditions. The neurologic infections identified by mNGS in these 7 participants represented a diverse array of pathogens. The patients were referred from the University of California, San Francisco Medical Center (n = 2), Zuckerberg San Francisco General Hospital and Trauma Center (n = 2), Cleveland Clinic (n = 1), University of Washington (n = 1), and Kaiser Permanente (n = 1). A weighted z score was used to filter out environmental contaminants and facilitate efficient data triage and analysis. Main Outcomes and Measures: Pathogens identified by mNGS and the ability of a statistical model to prioritize, rank, and simplify mNGS results. Results: The 7 participants ranged in age from 10 to 55 years, and 3 (43%) were female. A parasitic worm (Taenia solium, in 2 participants), a virus (HIV-1), and 4 fungi (Cryptococcus neoformans, Aspergillus oryzae, Histoplasma capsulatum, and Candida dubliniensis) were identified among the 7 participants by using mNGS. Evaluating mNGS data with a weighted z score-based scoring algorithm reduced the reported microbial taxa by a mean of 87% (range, 41%-99%) when taxa with a combined score of 0 or less were removed, effectively separating bona fide pathogen sequences from spurious environmental sequences so that, in each case, the causative pathogen was found within the top 2 scoring microbes identified using the algorithm. Conclusions and Relevance: Diverse microbial pathogens were identified by mNGS in the CSF of patients with diagnostically challenging subacute or chronic meningitis, including a case of subarachnoid neurocysticercosis that defied diagnosis for 1 year, the first reported case of CNS vasculitis caused by Aspergillus oryzae, and the fourth reported case of C dubliniensis meningitis. Prioritizing metagenomic data with a scoring algorithm greatly clarified data interpretation and highlighted the problem of attributing biological significance to organisms present in control samples used for metagenomic sequencing studies.

Indexed as

AdolescentAdultAnimalsAspergillus oryzaeCandidaCandidiasisChildChronic DiseaseCryptococcus neoformansFemaleHigh-Throughput Nucleotide SequencingHistoplasmaHistoplasmosisHIV-1HIV InfectionsHumans

Identifiers

PMID29710329
PMCPMC5933460
OpenAlexW2801729932

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.